Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3241 studies found for:    "Bacterial Infections"
Show Display Options
Rank Status Study
1 Unknown  Experimental Phage Therapy of Bacterial Infections
Condition: Bacterial Infections
Intervention: Other: Bacteriophage preparation
2 Recruiting Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections
Condition: Gram Positive Bacterial Infections
Intervention: Drug: Oritavancin
3 Completed Procalcitonin for Predicting Serious Bacterial Infection in Infants Less Than 3 Months
Conditions: Fever;   Bacterial Infection
4 Not yet recruiting Exposure to NSAIDs (Non Steroidal Anti-Inflammatory Drugs) and Severity of Community-acquired Bacterial Infections
Condition: Bacterial Infection
5 Completed Retrospective Examination of Initial Care of Severe Bacterial Infections of the Child
Condition: Bacterial Infection
Intervention: Other: Retrospective examination by experts whether care given fo child admitted at the ICU for suspicion of bacterial infection (not nosocomial) was optimal or not
6 Unknown  Efficacy Study of Community-Based Treatment of Serious Bacterial Infections in Young Infants
Conditions: Bacterial Infection;   Sepsis;   Infant, Newborn
Intervention: Drug: ceftriaxone, procaine penicillin and gentamicin, oral cotrimoxazole and gentamicin
7 Completed A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children
Conditions: Bacterial Infections;   Pneumonia, Pneumocystis Carinii;   HIV Infections
Interventions: Drug: Azithromycin;   Drug: Atovaquone;   Drug: Sulfamethoxazole-Trimethoprim
8 Recruiting Study Evaluate the PK Profile of Dalbavancin in Hospitalized Infants and Neonates Patients With Known or Suspected Bacterial Infection
Condition: Bacterial Infections
Intervention: Drug: Dalbavancin
9 Completed Value for Cord Blood Procalcitonin to Diagnose Early Neonatal Bacterial Infection
Condition: Neonatal Bacterial Infection
Intervention: Biological: dosage of the umbilical cord blood Procalcitonin for diagnosing of IBNP
10 Recruiting Fever and Shivering: Frequency and Role in Predicting Serious Bacterial Infection
Conditions: Febrile Shivering;   Severe Bacterial Infection
Intervention: Other: Ancillary tests
11 Recruiting Assessment of the Efficacy of FOSFOMYCIN in Patients With Bacterial Infection
Condition: Bacterial Infection
12 Unknown  The Rate of C-reactive Protein (CRP) Increase as a Marker for Bacterial Infections in Children
Conditions: Bacterial Infections;   Viral Infection
13 Completed Procalcitonin Level and Kinetics in Children With Bacterial Infections
Conditions: Bacterial Infections;   Bacteremia;   Meningitis;   Urinary Tract Infection;   Mastoiditis;   Lobar Pneumonia;   Septic Arthritis;   Cellulitis;   Osteomyelitis
14 Active, not recruiting The Value of the Neutrophil to Lymphocyte Ratio in the Diagnosis of Bacterial Infections
Condition: Bacterial Infections
Intervention: Biological: neutrophil to lymphocyte ratio
15 Recruiting Dose-finding, Pharmacokinetics, Safety, and Tolerability of Meropenem-Vaborbactam in Pediatric Subjects With Serious Bacterial Infections
Condition: Bacterial Infections
Intervention: Drug: Carbavance
16 Completed Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial Infections
Condition: Bacterial Infections
Intervention: Drug: Dalbavancin
17 Recruiting Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium + Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)
Condition: Bacterial Infections
Interventions: Drug: Imipenem+Cilastatin/Relebactam;   Drug: Colistimethate sodium (CMS);   Drug: Imipenem+Cilastatin;   Drug: Placebo to CMS
18 Completed Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units
Conditions: Gram-Positive Bacterial Infections;   Escherichia Coli Infections;   Klebsiella Infections
Intervention: Drug: piperacillin-tazobactam
19 Completed Safety, Pharmacokinetics (PK) and Tolerability Study of a Novel Drug for Treatment of Bacterial Infections
Condition: Gram-negative Bacterial Infection
Interventions: Drug: AN3365;   Drug: Placebo
20 Recruiting A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to <12 Years, With Confirmed or Suspected Bacterial Infection (MK-1986-013)
Condition: Gram-Positive Bacterial Infections
Interventions: Drug: Tedizolid Phosphate (IV);   Drug: Tedizolid Phosphate (oral suspension)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years